openPR Logo
Press release

Autoimmune Disease Diagnostics Market: Rise in Autoimmune Diseases, alongside Growing Awareness about Them, Stokes Market

08-28-2018 02:43 PM CET | Health & Medicine

Press release from: Transparency Market Research

Autoimmune Disease Diagnostics Market: Rise in Autoimmune

Global Autoimmune Disease Diagnostics Market: Snapshot

The global autoimmune disease diagnostics market is expected to witness a modest growth in the coming years on account of the growing incidences of autoimmune diseases among people worldwide. Efficient autoimmune disease diagnostics has become absolutely essential to tackle this issue. Governments across nations are also increasing their spending towards healthcare in light of these growing incidences of autoimmune diseases. This has also resulted in the research and development of novel diagnostics in order to prevent the spread of autoimmune diseases.

Obtain Report Details @ https://www.transparencymarketresearch.com/autoimmune-disease-diagnostics-market.html

Technological advancements in the medicals sector are also fueling the market’s growth. Between 2015 and 2023, the global autoimmune diseases diagnostics market is expected to exhibit a CAGR of 3.8%. The global autoimmune disease diagnostics market is likely to reach US$17.06 bn by 2023. The stiff price competition among players is expected to impact the growth of the market in a negative way.

North America to Continue to Lead in the Autoimmune Disease Diagnostics Market

By geography, North America is expected to lead in the autoimmune disease diagnostics market with the U.S. and Canada contributing the most to the market in the region. These countries have sophisticated healthcare infrastructure and laboratories with advanced techniques. There also exists high level of awareness regarding various medical procedures. The increased healthcare expenditure in the region will also be a contributing factor to the growth of the market in region.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5351

Asia Pacific is also expected to witness a rapid growth in the autoimmune disease diagnostics market on account of high demand from countries such as Malaysia, Australia, India, Japan, and China. Advancements in diagnostics devices will push the Asia Pacific autoimmune disease diagnostics market towards witnessing a CAGR of 4.3% between 2015 and 2023.

High Occurrence of Rheumatoid Arthritis to Drive Autoimmune Disease Diagnostics Market

Autoimmune diseases such as Graves’ disease, Hashimoto’s thyroiditis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, and type1 diabetes are prevalent commonly. Of these, the most prevalent of all diseases is rheumatoid arthritis, which can occur to people falling under any age group. The rheumatoid arthritis segment is estimated to be worth US$4.6 bn by the end of 2022. The growing geriatric population and improved diagnosis of rheumatoid arthritis at improved laboratories will drive the segment towards growth in the coming year. Apart from rheumatoid arthritis, the type 1 diabetes segment is expected to show a healthy growth and exhibit a CAGR of 3.7% between 2015 and 2023.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5351

Unavailability of Trained Professionals to Result in Operational Challenges

There is a dearth of trained professionals in the market which will hamper the growth of this market. In addition to this, a lack of automation will also pose a challenge and hamper the operations in clinical laboratories. Further, the threat of new entrants, mostly local players, will cause leading players to cut down their prices. Slashing down the prices of diagnostic devices so as to stay in the market and remain competitive is projected to have an adverse impact on the global autoimmune disease diagnostics market.

However, on the plus side, the market for autoimmune disease diagnostics is expected to find new opportunities for growth as leading players will leverage the untapped markets in emerging nations and capitalize on them. Players are also expected to concentrate on replacing traditional technologies with latest ones and automate the laboratories. This will help the market to grow. Additionally, the introduction of novel technologies will create promising growth for the market.

Popular Research Reports by TMR -

Bioprocess Technology Market: https://www.prnewswire.com/news-releases/bioprocess-technology-market-to-gain-us-43-916-6-mn-by-2026-says-tmr-813887478.html

Microfluidics Market: https://globenewswire.com/news-release/2018/07/11/1536015/0/en/Microfluidics-Market-to-generate-a-revenue-of-US-12-45-bn-by-2025-Says-TMR.html

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autoimmune Disease Diagnostics Market: Rise in Autoimmune Diseases, alongside Growing Awareness about Them, Stokes Market here

News-ID: 1206724 • Views:

More Releases from Transparency Market Research

Application Performance Monitoring Market Outlook 2031: Trends, Growth Drivers, …
In today's digital era, the performance of applications is pivotal for businesses, with speed, functionality, and user experience often determining success. The global Application Performance Monitoring (APM) Market is gaining momentum as enterprises increasingly rely on high-performing applications to drive productivity and customer satisfaction. According to recent market insights, the APM market, valued at US$ 5.9 billion in 2021, is anticipated to grow at a robust CAGR of 12.1% from
3D Reconstruction Technology Market Report: Innovations and Growth Opportunities …
As digital transformation and advanced imaging continue to redefine industries worldwide, 3D reconstruction technology stands out as a powerful enabler of immersive experiences, data accuracy, and operational efficiency. This technology, which spans components such as software and services, facilitates the generation of realistic 3D models from 2D images, scanned data, and videos. The global 3D reconstruction technology market, valued at US$ 995.4 million in 2021, is set to grow rapidly.
Oxycodone Hydrochloride Market Trends in Non-Opioid Alternatives - Predicted to expand to USD 675.2 million by 2034
Oxycodone Hydrochloride Market Trends in Non-Opioid Alternatives - Predicted to …
The Oxycodone Hydrochloride Market is set for moderate growth over the next decade, driven by the ongoing demand for effective pain management solutions and the increasing prevalence of chronic pain conditions. Valued at USD 403.9 million in 2023, the market is expected to grow at a compound annual growth rate (CAGR) of 4.8% from 2024 to 2034, reaching an estimated USD 675.2 million by the end of the forecast period.
Oxidative Stress Assays Market Future Directions in Cell-Based Assay Solutions - Estimated growth to USD 2.8 billion by 2034
Oxidative Stress Assays Market Future Directions in Cell-Based Assay Solutions - …
The global Oxidative Stress Assays Market is experiencing robust growth, driven by the rising demand for diagnostics and therapeutics focused on oxidative stress-related diseases. With a market valuation of USD 1.0 billion in 2023 and a projected compound annual growth rate (CAGR) of 9.4% through 2034, the market is anticipated to reach USD 2.8 billion by the end of the forecast period. This growth reflects a broader recognition of oxidative

All 5 Releases


More Releases for Autoimmune

Autoimmune Disease Diagnostics Market - Forecast to 2026
The findings reviewed by GME stated that the Global Autoimmune Disease Diagnostics Market would grow at a CAGR value of 8.9 percent from 2021 to 2026. Today, the advancing technology & automation, increasing awareness about risks and implications of autoimmune disease if left undiagnosed & untreated, and the awareness about the benefits of various diagnostics available are accelerating growth in the market. Also, there has been an exponential increase
The Autoimmune Registry releases first complete list of autoimmune diseases with …
The Autoimmune Registry Inc (ARI) has published its first comprehensive List of Autoimmune Diseases: https://www.autoimmuneregistry.org/autoimmune-diseases. It includes over 150 diseases, 40 subtypes, and 60 synonyms. ARI created the list to provide patients and researchers easy access to the latest literature and information about autoimmune disease. ARI’s list is searchable and filterable, with links to peer-reviewed research, patient groups, and other resources. Between 15 and 30 million people in
Autoimmune Disease Diagnostics Market: Growing Awareness among People about Auto …
According to the recent report by Transparency Market Research, the global autoimmune disease diagnostics market has a highly consolidated scenario. The market is dominated by a handful of players. However, these players have a stronghold over the dynamics of market and pose a great challenge for any new entrant to set its foot in the market. Read Report Overview - https://www.transparencymarketresearch.com/autoimmune-disease-diagnostics-market.html To reduce effects of such hindrances, the new entrants are
Autoimmune Disease Therapeutics Market Boost due to increase in incidence of aut …
According to a new report published by Allied Market Research, titled,"Autoimmune Disease Therapeutics Market by Drug Class, Indication, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025," the global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is expected to reach $153,320 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025. Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/5185?utm_source=openpr&utm_medium=Niranjan Autoimmune disease therapeutics include
Autoimmune Treatment Market North America Leads the Global Autoimmune Treatment …
The global autoimmune treatment market is growing significantly due to increasing incidences of autoimmune diseases, up surging healthcare expenditure, and advancements in the technologies for the development of autoimmune diseases therapeutics. Autoimmune diseases are chronic in nature and do not have permanent treatment. This creates ample growth opportunity for the autoimmune treatment market, to grow at a considerable rate in the coming years. The advanced research and development facilities, and
Autoimmune Disease Diagnostics Market: Growing Awareness Among People About Auto …
The global autoimmune disease diagnostics market is expected to witness a modest growth in the coming years on account of the growing incidences of autoimmune diseases among people worldwide. Efficient autoimmune disease diagnostics has become absolutely essential to tackle this issue. Governments across nations are also increasing their spending towards healthcare in light of these growing incidences of autoimmune diseases. This has also resulted in the research and development of